Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOsirium Tech Regulatory News (OSI)

  • This share is currently suspended. It was suspended at a price of 2.20
  • There is currently no data for OSI

Trading Update

8 Jul 2022 07:00

RNS Number : 7532R
Osirium Technologies PLC
08 July 2022
 

The information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended.

 

8 July 2022

 

Osirium Technologies plc

("Osirium" or the "Group")

 

Trading Update

 

Record half year performance for bookings and revenue

 

Osirium Technologies plc (AIM: OSI), a leading vendor of cloud-based cybersecurity and IT automation software, announces an update on trading for the six months ended 30 June 2022.

 

The positive trading momentum reported in the Company's Q1 2022 trading update has continued through Q2, and the Board expects to report the Group's best six-month figures for bookings and revenue:

 

·

Bookings increase of 30% to not less than £1.18 million (1H 2021: £0.91 million), with more than 50% of the value coming from new customer wins

·

Revenue of £0.91 million (1H 2021: £0.74 million)

·

Deferred revenue increased 14% to £1.91 million (1H 2021: £1.68 million), providing enhanced visibility

·

Debtors and cash balances as at 30 June 2022 were £0.61 million

 

The Board recognises that annualised recurring revenue ("ARR") is a key industry measurement of the size of a SaaS Company's subscription revenues and has decided to adopt this as a key performance indicator going forward. For June 2022, the Group's ARR* was £1.61 million, an increase of 11% since the start of the year (December 2021: £1.45 million) and 29% over the past 12 months (June 2021: £1.25 million).

 

The Group is pleased to report a continuing increase in average contract size amongst its new customer acquisitions. New contracts have been signed across a range of sectors during the period, including notable wins in healthcare, higher education and financial services. The Group expects these markets to continue to be key growth drivers in H2 and beyond.

 

In line with its land-and-expand strategy, Osirium has also expanded licenses with existing customers, including with a number of the Group's NHS customers signed in 2021.

 

Aided by its international channel partner network of resellers and distributors, the Group has signed deals in two new geographies, the USA and Finland, during H1.

 

The Group has seen the continued strong growth of its newer products. Increasing numbers of PAM customers are adding PPA and PEM to their environments and the Group also announced its first deals where these products were the main component during H1. The growth in demand for these products provides the important opportunity for cross-selling and up-selling.

 

Reflecting this cross-selling opportunity, Osirium is pleased to announce it has signed a contract expansion with an existing customer, a major UK provider of telephony and broadband services. Initially signed as a 36-month PAM deal in December 2020, this customer has now expanded its scope to include Osirium's PPA and PEM solutions. This sale, won in conjunction with Osirium's channel partner Nomios, is the first where all three Osirium privileged security products will be utilised.

 

With a good pipeline of opportunity ahead, an enhanced base of deferred revenue and an ongoing trend towards privileged security procurement, the Board remains confident of meeting revenue and bookings guidance for the full year. The Board maintains a focus on balancing investment alongside managing costs and will continue to ensure the appropriate structures are in place to support the growth strategy. As announced at the time of the Group's fundraising in February 2022, the Group will be required to raise additional capital in the second half of 2022 and the Board continues to assess all available options in this regard.

 

The Group expects to report its interim results for the period in September 2022.

 

* ARR is calculated by annualising revenue recognised in a given month from all clients on deployed subscription contracts

 

David Guyatt, Chief Executive Officer of Osirium said:

 

"Our record half for bookings and revenue shows the continued drive in the business as we increase our customer base as well as average total contract values. This is facilitated through the expansion of our products and additional licenses and our well-established channel partner network which extends into new territories underserved by our competitors.

 

"There remains an opportunity to scale the business significantly and I am pleased with the progress made in the first half of the year."

 

Contacts:

Osirium Technologies plc

Tel: +44 (0)1183 242 444

David Guyatt, CEO

Rupert Hutton, CFO

Allenby Capital Limited (Nominated adviser and broker)

Tel: +44 (0)20 3328 5656

James Reeve / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Alma PR (Financial PR adviser)

Tel: +44 (0)20 3405 0205

Hilary Buchanan

osirium@almapr.co.uk

Kieran Breheny

William Ellis Hancock

 

 

About Osirium Technologies Plc

 

Osirium Technologies plc (AIM: OSI) is a leading UK-based cybersecurity software vendor delivering Privileged Access Management (PAM), Privileged Endpoint Management (PEM) and Osirium Automation solutions that are uniquely simple to deploy and maintain. 

 

With privileged credentials involved in over 80% of security breaches, customers rely on Osirium PAM's innovative technology to secure their critical infrastructure by controlling 3rd party access, protecting against insider threats, and demonstrating rigorous compliance. Osirium Automation delivers time and cost savings by automating complex, multi-system processes securely, allowing them to be delegated to Help Desk engineers or end-users and to free up specialist IT resources. The Osirium PEM solution balances security and productivity by removing risky local administrator rights from users, while at the same time allowing escalated privileges for specific applications.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to trading on AIM in April 2016. For further information please visit www.osirium.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFEEDVIDIIF
Date   Source Headline
15th Oct 20207:00 amRNSContract win with leading healthcare provider
8th Oct 20207:00 amRNSCompetitive contract win with major UK Retailer
29th Sep 20207:00 amRNSInterim Results
21st Sep 20207:00 amRNSNotice of Results
16th Jun 202012:00 pmRNSResult of AGM
15th May 20207:00 amRNSFinal Results
8th Apr 20207:00 amRNSCOVID-19 Update and Contract Renewal
17th Mar 20207:00 amRNSContract win with major regional Ambulance Service
24th Feb 20203:46 pmRNSHolding(s) in Company
20th Feb 20207:00 amRNSContract win with major regional NHS Trust
20th Feb 20207:00 amRNSContract win with major regional NHS Trust
14th Jan 20207:00 amRNSTrading Update
11th Dec 20197:00 amRNSLaunch of Privileged Endpoint Manager solution
14th Nov 20195:25 pmRNSHolding(s) in Company
31st Oct 201910:48 amRNSTotal Voting Rights
30th Oct 201911:35 amRNSHolding(s) in Company
29th Oct 201912:09 pmRNSHolding(s) in Company
22nd Oct 20197:00 amRNSResult of fundraise
21st Oct 20197:00 amRNSProposed fundraise
10th Oct 20197:00 amRNSNew customer and upsell contract wins
23rd Sep 20197:00 amRNSSubstantial contract win
18th Sep 20197:00 amRNSHalf Year Report
10th Sep 20191:27 pmRNSNotice of Results
14th Aug 20197:00 amRNSFirst contract win for Opus
7th Aug 20197:00 amRNSContract wins
8th Jul 20197:00 amRNSTrading update
13th Jun 201912:07 pmRNSResult of AGM
6th Jun 20197:00 amRNSContract win
4th Jun 20197:00 amRNSInfosecurity Europe 2019
29th May 20197:00 amRNSHolding(s) in Company
17th May 20197:00 amRNSContract Extension
8th May 20197:00 amRNSFinal Results
1st May 20197:00 amRNSLaunch of secure IT Process Automation solution
29th Apr 20197:00 amRNSNotice of Final Results
18th Apr 20194:05 pmRNSHolding(s) in Company
22nd Mar 20194:30 pmRNSHolding(s) in Company
27th Feb 20197:00 amRNSContract wins
12th Feb 20197:00 amRNSContract win
14th Jan 20197:00 amRNSTrading Update
9th Jan 20191:59 pmRNSHolding(s) in Company
8th Jan 20197:00 amRNSContract win with major Business Energy player
19th Dec 20187:00 amRNSContract win with Financial Services provider
5th Oct 20187:00 amRNSGrant of options and PDMR dealings
25th Sep 20187:00 amRNSInterim results
21st Sep 20187:00 amRNSContract win with UK Fashion and Homeware Retailer
19th Sep 20187:00 amRNSStrategic Technology Partnership with RazorSecure
6th Aug 20187:00 amRNSNotice of Interim Results
24th May 201811:31 amRNSResult of AGM
14th May 201810:39 amRNSHolding(s) in Company
24th Apr 20187:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.